Cargando…
In vivo P-glycoprotein function before and after epilepsy surgery
OBJECTIVES: To study the functional activity of the multidrug efflux transporter P-glycoprotein (Pgp) at the blood-brain barrier of patients with temporal lobe epilepsy using (R)-[(11)C]verapamil (VPM)-PET before and after temporal lobe surgery to assess whether postoperative changes in seizure freq...
Autores principales: | Bauer, Martin, Karch, Rudolf, Zeitlinger, Markus, Liu, Joan, Koepp, Matthias J., Asselin, Marie-Claude, Sisodiya, Sanjay M., Hainfellner, Johannes A., Wadsak, Wolfgang, Mitterhauser, Markus, Müller, Markus, Pataraia, Ekaterina, Langer, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189097/ https://www.ncbi.nlm.nih.gov/pubmed/25186858 http://dx.doi.org/10.1212/WNL.0000000000000858 |
Ejemplares similares
-
A PET microdosing study with the P-glycoprotein inhibitor tariquidar
por: Bauer, Martin, et al.
Publicado: (2012) -
Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study
por: Bauer, Martin, et al.
Publicado: (2015) -
Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET
por: Bauer, Martin, et al.
Publicado: (2010) -
[(11)C]Elacridar as a novel P-glycoprotein PET tracer, assessment of whole-body distribution and radiation dosimetry in humans
por: Bauer, Martin, et al.
Publicado: (2011) -
Decreased blood-brain barrier P-glycoprotein function with aging
por: Bauer, Martin, et al.
Publicado: (2008)